Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Breast Cancer
Aug 30, 2023, 17:48 |
Blog
Bishal Gyawali: The tables in this paper will be supremely useful to anyone looking for a list of cancer drugs approved for breast cancer in the last decade.
In a post by Bishal Gyawali, an Associate Professor in medical oncology and public health…
Aug 30, 2023, 17:43 |
Insight
Arya Roy: Our new article: Oncotype Dx score and HER2- low expression in breast cancer published in Cancers MDPI!
In a post by Arya Roy, Hematology-Oncology Fellow at the Roswell Park Comprehensive Cancer Center,…
Aug 29, 2023, 19:14 |
Stories
Cynthia Jordan: Met Bec’s from Australia with Stage 2 Lobular Carcinoma Breast Cancer.
Cynthia Jordan, the Founder and CEO at Learn Look Locate, recently posted on LinkedIn: "Met…
Aug 24, 2023, 18:16 |
Blog
Paolo Tarantino: Retrospective study by Viale et al. on HER2-low breast cancer.
Quoting Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, on Twitter: ''Just out on…
Aug 20, 2023, 16:16 |
Blog
Janine E. Guglielmino: Today is my final day at Living Beyond Breast Cancer.
Quoting Janine E. Guglielmino, the Vice President of Mission Delivery at Living Beyond Breast Cancer,…
Aug 19, 2023, 20:05 |
Insight
Why patients with triple negative breast cancer respond differently to treatment. - The Institute of Cancer Research
The Institute of Cancer Research, made the following remark on Twitter: "Our scientists have looked into…
Aug 19, 2023, 17:44 |
Insight
Kathryn Gallaway: Continuing our discussion on disparities in breast cancer.
Quoting Kathryn Gallaway, the Associate Medical Director of DAVA Oncology, on Twitter: "Continuing our discussion…
Aug 18, 2023, 16:55 |
Blog
Targeting Mutant ER: Geoffrey L. Greene, François-Clément Bidard, and Erika P. Hamilton will address this topic in a State-of-the-Art session at SABCS23 - San Antonio Breast Cancer Symposium
Aug 18, 2023, 04:56 |
Insight
Nicola Fusco: The assessment of PDL1 Combined Positive Score (CPS)≥10 in metastatic triple-negative breast cancer.
Nicola Fusco, an Associate Professor at the Department of Oncology and Hemato-Oncology at the University…
Aug 16, 2023, 18:20 |
Opinion
James Coyne: The article provides a summary of my thinking about a seriously flawed study that gave false hope to breast cancer patients.
Quoting from a recent LinkedIn post by James Coyne, Emeritus Professor of Psychology in Psychiatry…
62
63
64
65
66
All:
2562
Posts:
631 - 640
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube